Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenza.
Chavant F, Ingrand I, Jonville-Bera AP, Plazanet C, Gras-Champel V, Lagarce L, Zenut M, Disson-Dautriche A, Logerot S, Auffret M, Coubret-Dumas A, Bruel ML, Boyer M, Bos-Thompson MA, Veyrac G, Carlier P, Beyens MN, Lates S, Damase-Michel C, Castot A, Kreft-Jaïs C, Pérault-Pochat MC. Chavant F, et al. Among authors: beyens mn. Drug Saf. 2013 Jun;36(6):455-65. doi: 10.1007/s40264-013-0030-1. Drug Saf. 2013. PMID: 23516007
First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
Durrieu G, Palmaro A, Pourcel L, Caillet C, Faucher A, Jacquet A, Ouaret S, Perault-Pochat MC, Kreft-Jais C, Castot A, Lapeyre-Mestre M, Montastruc JL; French Network of Pharmacovigilance Centres. Durrieu G, et al. Drug Saf. 2012 Oct 1;35(10):845-54. doi: 10.1007/BF03261980. Drug Saf. 2012. PMID: 22967189
Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009-2010 mass vaccination campaign in France.
Caillet C, Durrieu G, Jacquet A, Faucher A, Ouaret S, Perrault-Pochat MC, Kreft-Jaïs C, Castot A, Montastruc JL; French Network of Pharmacovigilance Centres. Caillet C, et al. Eur J Clin Pharmacol. 2011 Jun;67(6):649-51. doi: 10.1007/s00228-010-0961-8. Epub 2010 Dec 14. Eur J Clin Pharmacol. 2011. PMID: 21153631 No abstract available.
Thromboembolic events in women exposed to hormonal contraception or cyproterone acetate in 2012: a cross-sectional observational study in 30 French public hospitals.
Gourbil M, Grandvuillemin A, Beyens MN, Massy N, Gras V, D'Amico A, Miremont-Salamé G, Petitpain N; French Network of Regional Pharmacovigilance Centres. Gourbil M, et al. Among authors: beyens mn. Drug Saf. 2014 Apr;37(4):269-82. doi: 10.1007/s40264-014-0149-8. Drug Saf. 2014. PMID: 24634164
Evaluating Twitter as a complementary data source for pharmacovigilance.
Lardon J, Bellet F, Aboukhamis R, Asfari H, Souvignet J, Jaulent MC, Beyens MN, Lillo-LeLouët A, Bousquet C. Lardon J, et al. Among authors: beyens mn. Expert Opin Drug Saf. 2018 Aug;17(8):763-774. doi: 10.1080/14740338.2018.1499724. Epub 2018 Jul 26. Expert Opin Drug Saf. 2018. PMID: 29991282
42 results